AiCuris nominates Madam Therapeutics as the first winner of the AiCubator Resident Status in 2022, a corporate innovation accelerator initiative
On Aril 8th 2022, AiCuris announced at the BIOCOM AMR Conference 2022 that it has selected Madam Therapeutics with its unique peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022, a corporate innovation …